Sectors Covered   Completed Transactions   Testimonials   Principals   M&A Report 
 and Publications 
 Contact Us 












Dynamic Healthcare M&A Database - 3Q07



Return to the Summary Page (3Q07)



Acquiring Party    ReAble Therapeutics, Inc. (formerly Encore Medical), a diversified rehabilitation and orthopedic device company and an affiliate of The Blackstone Group.
Transferring Party    IOMED, Inc. (Amex:IOX), a leading manufacturer of pain management drug-delivery devices focused primarily on iontophoresis (drug delivery transdermally using electric current to ionize drug molecules and propel them through the skin).
Sector    Medical Devices
Date    August 9, 2007
Analysis
This is an add-on acquisition by Blackstone, which acquired ReAble in '06. IOMED's pain management drug delivery devices complement offerings of ReAble's Empi pain management and rehab division. IOMED has a field sales force and sizeable distribution system. ReAble also distributes electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Deal value - $22m, on sales of $9.1m (2.4x) and negative EBTIDA.




The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones.

This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc.


The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.